Association between interleukin 4 (IL-4) VNTR, gene polymorphism, and breast cancer susceptibility in Iranian population: experimental and web base analysis

被引:12
作者
Ibrahimi, M. [1 ,2 ]
Jamalzei, B. [1 ,2 ]
Akbari, M. E. [1 ]
Ibrahimi, R. [1 ]
Alaei, M. [1 ]
Moossavi, M. [1 ,3 ,4 ]
Mohammadoo-Khorasani, M. [1 ,2 ]
机构
[1] Shahid Beheshti Univ Med Sci, Canc Res Ctr, Tehran, Iran
[2] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran
[3] Birjand Univ Med Sci, Res Comm, Birjand, Iran
[4] Birjand Univ Med Sci, Dept Mol Med, Birjand, Iran
来源
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2018年 / 119卷 / 10期
关键词
IL-4; breast cancer; VNTR polymorphism; SQUAMOUS-CELL CARCINOMA; CYTOKINE LEVELS; RISK; SURVIVAL; THERAPY; PLASMA; INFLAMMATION; EXPRESSION; BIOMARKERS; MARKERS;
D O I
10.4149/BLL_2018_116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Breast cancer (BC) is one of the most common types of cancer and the second leading cause of cancer death among women. Epidemiological studies showed that BC is linked to genetic and environmental factors, and inheritance plays a key role in the pathobiology of this disease. Interleukin 4 (IL-4) is a key differentiation cytokine and is produced by Th2 and activates Th2 development. Hence the current study aimed to assess the possible association between interleukin 4 (IL-4) VNTR polymorphism, and BC susceptibility in a sample of Iranian population. MATERIAL AND METHODS: IL-4 VNTR polymorphism was evaluated in 150 women with BC and 150 age-matched healthy women by polymerase chain reaction method. RESULT: Among 3 possible alleles for IL-4 gene, we only observed 2 alleles. Current findings indicate that RP2/RP2 genotypes can be regarded as potent protective factors against breast cancer (OR = 0.929 [95% CI, 0.929-0.995]). CONCLUSION: Our result showed that the RP2/RP2 genotype of the IL-4 VNTR polymorphism could be a protective factor for BC susceptibility.
引用
收藏
页码:651 / 654
页数:4
相关论文
共 45 条
  • [1] Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action
    Abaza, M. S. I.
    Bahman, A. M.
    Al-Attiyah, R. J.
    Kollamparambil, A. M.
    [J]. TUMOR BIOLOGY, 2012, 33 (06) : 1951 - 1972
  • [2] Adab FK, 2017, IRAN J CANCER PREV, V10, DOI 10.17795/ijcp-6428
  • [3] Al-Ghurabi BH., 2009, J FM BAGHDAD, V51, P300
  • [4] The IL-1RN and IL-4 gene polymorphisms are potential genetic markers of susceptibility to bladder cancer: a case-control study
    Bozdogan, S. T.
    Erol, B.
    Dursun, A.
    Bozdogan, G.
    Donmez, I.
    Mungan, N. A.
    Seydaoglu, G.
    [J]. WORLD JOURNAL OF UROLOGY, 2015, 33 (03) : 389 - 395
  • [5] Genetic Evidence for the Aggravation of Plasmodium falciparum Malaria by Interleukin 4
    Cabantous, Sandrine
    Poudiougou, Belco
    Oumar, Aboubacar A.
    Traore, Abdoualye
    Barry, Abdoulaye
    Vitte, Joana
    Bongrand, Pierre
    Marquet, Sandrine
    Doumbo, Ogobara
    Dessein, Alain J.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (10) : 1530 - 1539
  • [6] Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    Carey, Lisa A.
    Perou, Charles M.
    Livasy, Chad A.
    Dressler, Lynn G.
    Cowan, David
    Conway, Kathleen
    Karaca, Gamze
    Troester, Melissa A.
    Tse, Chiu Kit
    Edmiston, Sharon
    Deming, Sandra L.
    Geradts, Joseph
    Cheang, Maggie C. U.
    Nielsen, Torsten O.
    Moorman, Patricia G.
    Earp, H. Shelton
    Millikan, Robert C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2492 - 2502
  • [7] Recent ASCO Guideline on the Use of Biomarkers for Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer
    Copur, Mehmet S.
    Ramaekers, Ryan
    Gauchan, Dron
    Norvell, Max
    Clark, Douglas
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (32) : 3943 - +
  • [8] How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?
    Crew, Katherine D.
    Albain, Kathy S.
    Hershman, Dawn L.
    Unger, Joseph M.
    Lo, Shelly S.
    [J]. NPJ BREAST CANCER, 2017, 3
  • [9] Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer
    Dowsett, Mitch
    Dunbier, Anita K.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (24) : 8019 - 8026
  • [10] Association between interleukin-4 gene intron 3 VNTR polymorphism and cancer risk
    Duan, Yin
    Pan, Chi
    Shi, Jinan
    Chen, Hailong
    Zhang, Suzhan
    [J]. CANCER CELL INTERNATIONAL, 2014, 14